Lexicon Pharmaceuticals
LXRX
#6605
Rank
S$1.07 B
Marketcap
S$2.41
Share price
5.62%
Change (1 day)
30.23%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2023 (TTM): S-$0.92

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S-$0.19. In 2022 the company made an earnings per share (EPS) of S-$0.78 an increase over its 2021 EPS that were of S-$0.78.

EPS history for Lexicon Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S-$0.9218.43%
2022S-$0.78-0%
2021S-$0.7810.91%
2020S-$0.70-145.08%
2019S$1.56-206.09%
2018S-$1.47-5.74%
2017S-$1.56-10.95%
2016S-$1.752640%
2015S-$0.06400-96.34%
2014S-$1.75-2.53%
2013S-$1.79-9.09%
2012S-$1.97-37.14%
2011S-$3.140%
2010S-$3.14-39.66%
2009S-$5.203.57%
2008S-$5.02-8.2%
2007S-$5.47-24.69%
2006S-$7.2642.11%
2005S-$5.11-22.97%
2004S-$6.63-35.09%
2003S-$10.21-0%
2002S-$10.2162.86%
2001S-$6.27-19.54%
2000S-$7.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
S$24.31-12,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$7.54-4,026.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$53.64-28,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S-$7.48 3,793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$12.81-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S-$0.02560-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S-$0.96 400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.49-353.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S-$37.49 19,426.67%๐Ÿ‡บ๐Ÿ‡ธ USA